The phase II clinical trial to be conducted by the University and BioGenCell will focus on patient responses to novel cell therapy, with the aim of saving limbs and enabling a better quality of life for those suffering [California, USA, April 20, 2023] –  BioGenCell, the leading personalized cell therapy […]